Cargando…
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report
Autores principales: | Gelato, Federica, Mastorino, Luca, Cavalla, Paola, Quaglino, Pietro, Cavaliere, Giovanni, Vercellino, Marco, Bosa, Chiara, Inglese, Matilde, De Palma, Raffaele, Ortoncelli, Michela, Ribero, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788158/ https://www.ncbi.nlm.nih.gov/pubmed/35899485 http://dx.doi.org/10.1111/dth.15740 |
Ejemplares similares
-
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023) -
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
por: Mastorino, Luca, et al.
Publicado: (2022) -
Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis
por: Miniotti, Marco, et al.
Publicado: (2022) -
Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study
por: Mastorino, Luca, et al.
Publicado: (2021) -
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis
por: Mastorino, Luca, et al.
Publicado: (2022)